Indofarma Tbk. vs Keramika Indonesia Assosiasi Tbk. — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Keramika Indonesia Assosiasi Tbk. trades at Rp21 (market cap 313.51B). The key difference: Indofarma Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| INAF | KIAS | |
|---|---|---|
Market Cap | 390.51B | 313.51B |
Trailing returns across standard periods
Latest headlines on both assets
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Read more on INAF →KIA Group is one of the most diversified ceramic manufacturers in Indonesia, manufacturing Floor tiles (KSM), wall ties (KIA) and roof tiles (KKM). From their modest origins, a small ceramic tableware producer in the 1950s, KIA Group has to grown up to become Indonesias leading ceramic building material manufacturer. KIA Group received official recognition of its quality management system standard from SGS certification ISO 9002 no. Q4724 in 1995. In addition, KIA Group is in compliance with the World Bank Environmental and Social Policy Standard.
Read more on KIAS →